# What's New in Diabetic Polyneuropathy Research

---

## Randomized Controlled Trials

**Improving postural stability with proprioceptive rehabilitation in patients with diabetic polyneuropathy: a double-blind randomised controlled trial.**  
A double-blind RCT demonstrated that a 12-week proprioceptive rehabilitation program produced greater improvements in postural stability and reduction in postural sway than conventional balance and strength training in patients with diabetic polyneuropathy, potentially reducing fall risk and improving quality of life.  
_Citation: Improving postural stability with proprioceptive rehabilitation in patients with diabetic polyneuropathy, BMJ open sport & exercise medicine, 01/01/2025, PMID: 40357056 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40357056))_

**Effect of Trans-Auricular Vagal Nerve Stimulation on Cognitive Functions in Diabetic Polyneuropathy Patients.**  
A randomized controlled trial found that adding trans-auricular vagal nerve stimulation to computer-based cognitive rehabilitation significantly enhanced cognitive functions and quality of life in diabetic polyneuropathy patients compared to cognitive rehabilitation alone.  
_Citation: Effect of Trans-Auricular Vagal Nerve Stimulation on Cognitive Functions in Diabetic Polyneuropathy Patients, Physiotherapy research international, 04/01/2025, PMID: 40285458 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40285458))_

**Nonpharmaceutical treatment of distal sensorimotor polyneuropathy in diabetic patients: an unblinded randomized clinical trial.**  
This trial suggests that both heated granulated stone therapy and electrical stimulation (four-chamber galvanic bath) improve symptoms of diabetic distal sensorimotor polyneuropathy, with heated stone therapy showing potential as a novel non-pharmaceutical option.  
_Citation: Nonpharmaceutical treatment of distal sensorimotor polyneuropathy in diabetic patients: an unblinded randomized clinical trial, BMC complementary medicine and therapies, 03/06/2025, PMID: 40050870 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40050870))_

---

## Observational Studies (cohort studies, case-control studies, cross-sectional studies)

**Assessing Diabetic Polyneuropathy Prevalence in Hospitalized Patients: A Comparative Study Using the Michigan Self-Report Questionnaire and Physical Examination Methods.**  
A cross-sectional study found high prevalence (64.6%) of diabetic polyneuropathy among hospitalized diabetic patients; moderate agreement was noted between Michigan self-report questionnaire and physical examination as screening tools.  
_Citation: Assessing Diabetic Polyneuropathy Prevalence in Hospitalized Patients, Journal of diabetes research, 01/01/2025, PMID: 40524725 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40524725))_

**Progressive improvements in patient-reported outcomes with the high-concentration capsaicin patch: A retrospective cohort study in patients with painful diabetic peripheral neuropathy (CASPAR study).**  
Retrospective data from over 800 patients showed long-term, successive improvements in pain, sleep, quality of life, and reduction in pain medication with repeated use of high-concentration capsaicin patches in painful diabetic peripheral neuropathy.  
_Citation: Progressive improvements in patient-reported outcomes with the high-concentration capsaicin patch, Journal of diabetes and its complications, 09/01/2025, PMID: 40499399 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40499399))_

**Estimating the Risk of Lower Extremity Complications in Adults Newly Diagnosed With Diabetic Polyneuropathy: Retrospective Cohort Study.**  
A large retrospective study developed and validated a machine learning algorithm using electronic health records to accurately predict lower extremity complications after initial diabetic polyneuropathy diagnosis.  
_Citation: Estimating the Risk of Lower Extremity Complications in Adults Newly Diagnosed With Diabetic Polyneuropathy, JMIR diabetes, 05/29/2025, PMID: 40440641 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40440641))_

**Artificial Intelligence Algorithm to Screen for Diabetic Neuropathy: A Pilot Study.**  
A cross-sectional study evaluated an AI algorithm for identifying diabetic polyneuropathy risk in type 2 diabetes patients, noting moderate agreement with an instrument-based diagnosis and supporting its potential to guide targeted screening.  
_Citation: Artificial Intelligence Algorithm to Screen for Diabetic Neuropathy: A Pilot Study, Biomedicines, 04/29/2025, PMID: 40426905 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40426905))_

**A longitudinal study of paradoxical heat sensation in 420 individuals.**  
This longitudinal study found that paradoxical heat sensation is associated with early thermal sensory loss in diabetic polyneuropathy, suggesting it could be an early marker for neuropathy progression.  
_Citation: A longitudinal study of paradoxical heat sensation in 420 individuals, Pain, 05/20/2025, PMID: 40408231 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40408231))_

**Neuropathic pain in diabetic polyneuropathy: a 5-year prospective study.**  
In a 5-year prospective study, risk factors for developing and relieving neuropathic pain in diabetic polyneuropathy included female sex, dysesthesia, sensory deficits, and metabolic measures, with dynamic changes observed in pain status over time.  
_Citation: Neuropathic pain in diabetic polyneuropathy: a 5-year prospective study, Pain, 05/13/2025, PMID: 40359373 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40359373))_

**Transcutaneous Application of Gaseous CO₂ Improves Diabetic Distal Symmetrical Polyneuropathy in Patients with and Without Chronic Wounds.**  
A controlled study of CO₂ therapy demonstrated significant sensory and temperature improvements in diabetic patients with or without foot ulcers, indicating it is a well-tolerated and effective adjunct for diabetic polyneuropathy.  
_Citation: Transcutaneous Application of Gaseous CO₂ Improves Diabetic Distal Symmetrical Polyneuropathy in Patients with and Without Chronic Wounds, The international journal of lower extremity wounds, 05/06/2025, PMID: 40326000 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40326000))_

**Glial fibrillary acidic protein: a potential biomarker for small fiber neuropathy?**  
Serum GFAP levels were significantly reduced in diabetic polyneuropathy and correlated with cold pain threshold, suggesting it may serve as a marker for small fiber neuropathy.  
_Citation: Glial fibrillary acidic protein: a potential biomarker for small fiber neuropathy?, Acta diabetologica, 04/07/2025, PMID: 40192786 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40192786))_

**Are Inflammatory Markers Important for Assessing the Severity of Diabetic Polyneuropathy?**  
This retrospective analysis found that various inflammatory markers and lipid indices are associated with the severity of diabetic polyneuropathy and could provide a simple, low-cost tool for risk assessment in clinical practice.  
_Citation: Are Inflammatory Markers Important for Assessing the Severity of Diabetic Polyneuropathy?, Medicina (Kaunas, Lithuania), 02/25/2025, PMID: 40142211 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40142211))_

**Serum Neurofilament Light Chain and Structural and Functional Nerve Fiber Loss in Painful and Painless Diabetic Polyneuropathy.**  
Higher serum neurofilament light chain (NfL) was associated with nerve fiber dysfunction and structural loss, but not with pain or clinical severity scales, indicating that s-NfL may reflect underlying nerve damage in diabetic polyneuropathy.  
_Citation: Serum Neurofilament Light Chain and Structural and Functional Nerve Fiber Loss in Painful and Painless Diabetic Polyneuropathy, Diabetes research and clinical practice, 05/01/2025, PMID: 40118191 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40118191))_

**What does nerve ultrasound contribute to the evaluation of diabetic polyneuropathy over time? A prospective follow-up observational study of people with type 2 diabetes.**  
Longitudinal ultrasound of peripheral nerves in type 2 diabetes showed minimal changes and limited value for diagnosing or monitoring diabetic polyneuropathy compared to nerve conduction studies.  
_Citation: What does nerve ultrasound contribute to the evaluation of diabetic polyneuropathy over time?, Diabetes research and clinical practice, 04/01/2025, PMID: 40113173 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40113173))_

**Assessment of nerve conduction velocity slowing and its association with the severity of diabetic polyneuropathy, duration of diabetes and glycemic control in diabetic patients.**  
A prospective study revealed that slowing of nerve conduction velocity is significantly linked to disease duration, poor glycemic control, and severity of neuropathy in diabetic patients.  
_Citation: Assessment of nerve conduction velocity slowing..., Pakistan journal of medical sciences, 03/01/2025, PMID: 40103903 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40103903))_

**Biochemical use of neurofilament light polypeptide and vitamin B₁₂ in relation to diabetic polyneuropathy in Danish adolescents with type 1 diabetes: a cross-sectional study.**  
No difference in neurofilament light or vitamin B₁₂ status was found between adolescents with or without diabetic polyneuropathy, suggesting neither are useful cross-sectional biomarkers in this population.  
_Citation: Biochemical use of neurofilament light polypeptide and vitamin B₁₂ in relation to diabetic polyneuropathy in Danish adolescents with type 1 diabetes, BMJ open, 03/03/2025, PMID: 40032364 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40032364))_

**Association between adiponectin single nucleotide polymorphisms and the risk of diabetic polyneuropathy.**  
This genetic association study identified specific adiponectin gene polymorphisms that may confer increased or decreased risk of developing diabetic polyneuropathy and influence disease severity in Egyptians.  
_Citation: Association between adiponectin single nucleotide polymorphisms and the risk of diabetic polyneuropathy, Scientific reports, 01/31/2025, PMID: 39890883 ([link](https://www.ncbi.nlm.nih.gov/pubmed/39890883))_

**Chronic Microvascular Complications in Sulfonylureas-Treated Diabetic Patients: Correlations with Glycemic Control, Risk Factors and Duration of the Disease.**  
Among sulfonylurea-treated diabetic patients, polyneuropathy prevalence was linked to hyperlipidemia and overweight/obesity, emphasizing the role of comorbidities in microvascular complication risk.  
_Citation: Chronic Microvascular Complications in Sulfonylureas-Treated Diabetic Patients, Clinics and practice, 12/30/2024, PMID: 39851790 ([link](https://www.ncbi.nlm.nih.gov/pubmed/39851790))_

**Diabetes and Cataracts Development-Characteristics, Subtypes and Predictive Modeling Using Machine Learning in Romanian Patients: A Cross-Sectional Study.**  
Machine learning analysis in diabetic patients showed that the presence and duration of diabetes and diabetic polyneuropathy strongly influenced the risk and subtype of cataract, particularly cortical cataracts.  
_Citation: Diabetes and Cataracts Development-Characteristics, Subtypes and Predictive Modeling Using Machine Learning in Romanian Patients, Medicina (Kaunas, Lithuania), 12/28/2024, PMID: 39859011 ([link](https://www.ncbi.nlm.nih.gov/pubmed/39859011))_

---

## Basic Science Research

*No entries in this section for the current search period.*

---

## Meta-analyses and Systematic Reviews

**Network Meta-analysis of Randomized Controlled Trials Assessing Neuromodulation Therapies for Painful Diabetic Neuropathy.**  
A systematic review and network meta-analysis showed that various neuromodulation therapies, especially spinal cord stimulation and TENS, can reduce pain intensity in painful diabetic neuropathy, with implications for treatment choice and clinical guidelines.  
_Citation: Network Meta-analysis of Randomized Controlled Trials Assessing Neuromodulation Therapies for Painful Diabetic Neuropathy, Neurology and therapy, 08/01/2025, PMID: 40358907 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40358907))_

**Neural networks involved in painful diabetic neuropathy: A systematic review.**  
Systematic review of neuroimaging studies revealed significant alterations in brain pain networks in painful diabetic polyneuropathy, identifying potential neural targets for neuromodulation treatments.  
_Citation: Neural networks involved in painful diabetic neuropathy: A systematic review, Scandinavian journal of pain, 01/01/2025, PMID: 40197380 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40197380))_

---

## Narrative Reviews

**Is Exercise Enough? Integrating Pharmacological and Physical Therapy Approaches in the Management of Diabetic Polyneuropathy - A Narrative Review.**  
This review discusses the roles of exercise and pharmacological therapies in diabetic polyneuropathy management, emphasizing the potential benefits of a combined, multimodal approach for symptom reduction and improved patient outcomes.  
_Citation: Is Exercise Enough? Integrating Pharmacological and Physical Therapy Approaches in the Management of Diabetic Polyneuropathy, Journal of pharmacy & bioallied sciences, 06/01/2025, PMID: 40655655 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40655655))_

**[Early diagnosis and effective therapy of diabetic polyneuropathy].**  
This narrative review summarizes the pathogenesis, diagnostic strategies, and therapeutic options for diabetic polyneuropathy, highlighting the importance of early detection and advocating for combined lifestyle and pharmacologic interventions, including alpha-lipoic acid and benfotiamine.  
_Citation: [Early diagnosis and effective therapy of diabetic polyneuropathy], Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 01/01/2025, PMID: 40457669 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40457669))_

**A narrative literature review about alpha-lipoic acid role in dry eye and ocular surface disease.**  
This review highlights the antioxidant and neuroprotective roles of alpha-lipoic acid, describing its potential benefits for ocular surface disease, diabetic retinopathy, and diabetic polyneuropathy, though further research is needed.  
_Citation: A narrative literature review about alpha-lipoic acid role in dry eye and ocular surface disease, Acta ophthalmologica, 04/10/2025, PMID: 40207422 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40207422))_

**The overlap of diabetic and inflammatory neuropathies: Epidemiology, possible mechanisms, and treatment implications.**  
This review explores the epidemiology and mechanisms of overlap between diabetic polyneuropathy and inflammatory neuropathies, stressing the need for clinician awareness and proper diagnostic differentiation due to important treatment considerations.  
_Citation: The overlap of diabetic and inflammatory neuropathies, Clinical neurology and neurosurgery, 02/01/2025, PMID: 39798331 ([link](https://www.ncbi.nlm.nih.gov/pubmed/39798331))_

---

## Case Reports & Case Series

**A case report: preceding diagnosis of type 2 diabetes by severe neuropathic pain arising from diabetic polyneuropathy.**  
This case report describes a patient whose diagnosis of type 2 diabetes was prompted by severe, diffuse neuropathic pain and diabetic polyneuropathy, highlighting the need for awareness of neuropathic symptoms as potential early indicators of diabetes.  
_Citation: A case report: preceding diagnosis of type 2 diabetes by severe neuropathic pain arising from diabetic polyneuropathy, Diabetology international, 07/01/2025, PMID: 40607149 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40607149))_

---

## Other

**[Potential of animal-derived neuropeptides in complex therapy of diabetic neuropathy in patients with type 2 diabetes mellitus].**  
This article reviews the emerging use of animal-derived neuropeptides, such as Cortexin, for addressing cognitive dysfunction and chronic neuropathic pain in diabetic neuropathy, suggesting potential for future clinical trials.  
_Citation: [Potential of animal-derived neuropeptides in complex therapy of diabetic neuropathy in patients with type 2 diabetes mellitus], Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 01/01/2025, PMID: 40350733 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40350733))_

**Effect of Transcutaneous Application of Carbon Dioxide on Wound Healing, Wound Recurrence Rate and Diabetic Polyneuropathy in Patients with Neuropathic, Ischemic and Neuroischemic Diabetes-Related Foot Ulcers.**  
Transcutaneous CO₂ therapy led to significant improvements in healing rates, sensation, and reduction in recurrence of diabetic foot ulcers and polyneuropathy, proposing it as a promising adjunct therapy.  
_Citation: Effect of Transcutaneous Application of Carbon Dioxide on Wound Healing, Wound Recurrence Rate and Diabetic Polyneuropathy in Patients with Neuropathic, Ischemic and Neuroischemic Diabetes-Related Foot Ulcers, Life (Basel, Switzerland), 04/07/2025, PMID: 40283172 ([link](https://www.ncbi.nlm.nih.gov/pubmed/40283172))_

**Epidermal Transient Receptor Potential Vanilloid 1 innervation is increased in patients with painful diabetic polyneuropathy experiencing ongoing burning pain.**  
In patients with painful diabetic polyneuropathy and burning pain, intraepidermal TRPV1 nerve fiber density is increased, highlighting TRPV1 as a potential target for pain management in this condition.  
_Citation: Epidermal Transient Receptor Potential Vanilloid 1 innervation is increased in patients with painful diabetic polyneuropathy..., Pain, 04/01/2025, PMID: 39968935 ([link](https://www.ncbi.nlm.nih.gov/pubmed/39968935))_

---
